<DOC>
	<DOCNO>NCT01903122</DOCNO>
	<brief_summary>The objective study prove bioequivalence Roxane Laboratories ' Cevimeline 30 mg fast condition</brief_summary>
	<brief_title>Crossover Bioequivalence Study Cevimeline 30 mg Capsules Under Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Cevimeline</mesh_term>
	<criteria>No clinically significant abnormal finding physical examination , medical history , clinical laboratory result screen Positive test HIV , Hepatitis B , Hepatitis C. Treatment know enzyme alter drug . History allergic adverse response cevimeline comparable similar product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>